No Data
Optimism Around Yantai Dongcheng Pharmaceutical GroupLtd (SZSE:002675) Delivering New Earnings Growth May Be Shrinking as Stock Declines 4.0% This Past Week
Yantai Dongcheng Biochemicals (002675.SZ) distribution of equity for the first three quarters: 0.5 yuan for every 10 shares.
Yantai Dongcheng Biochemicals (002675.SZ) announced that the company's equity distribution plan for the first three quarters of 2024 is as follows: based on public ...
Yantai Dongcheng Biochemicals (002675.SZ): Tosei Nuclear Medical received a government subsidy of 30 million yuan.
On December 10, Geelonghui reported that Yantai Dongcheng Biochemicals (002675.SZ) announced that recently, Dongcheng Nuclear Medical received government subsidy funds of 30 million yuan from the Finance Bureau of Yantai's Muping District.
zheshang Securities: Nuclear technology applications have wide downstream applications and enormous growth potential.
In 2022, the output value of non-power nuclear technology applications in our country accounted for approximately 0.57% of GDP, showing significant growth potential compared to developed countries overseas (which account for 2-3% of GDP).
Yantai Dongcheng Pharmaceutical Group Co.,Ltd.'s (SZSE:002675) Stock Going Strong But Fundamentals Look Weak: What Implications Could This Have On The Stock?
Deng Xiaofeng newly invested in a resource stock.
Private equity tycoons Feng Liu and Deng Xiaofeng's latest holdings are here! In the third quarter, Feng Liu's managed Gaoyi Linshan No. 1 Yuanwang Fund entered the top ten list of tradable shareholders of 10 A-share companies, with a total market cap of approximately 19.538 billion yuan. Specifically, in the third quarter, Feng Liu increased his holdings in Beijing Tongrentang, Yantai Dongcheng Biochemicals, and Jonjee Hi-Tech Industrial and Commercial Holding; reduced his holdings in Angel Yeast Co., Ltd. and Nanjing King-Friend Biochemical Pharmaceutical; maintained his position unchanged in Hangzhou Hikvision Digital Technology, LB Group Co., Ltd., Shengyi Technology, Xinxiang Richful Lube Additive, and Shanghai Titan Scientific Co., Ltd. Deng Xiaofeng's managed Gaoyi Xiaofeng No. 2 Fund entered the top ten list of tradable shareholders of 13 A-share companies in the third quarter, with a total market cap of approximately 7.917 billion yuan. Gaoyi Xiaofeng Hongyuan Fund
Why We're Not Concerned About Yantai Dongcheng Pharmaceutical Group Co.,Ltd.'s (SZSE:002675) Share Price
